Back to Search
Start Over
Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast Comparação do grau nuclear e perfil imunoistoquímico nos componentes in situ e invasivo de carcinoma mamário
- Source :
- Revista Brasileira de Ginecologia e Obstetrícia, Vol 35, Iss 3, Pp 97-102 (2013)
- Publication Year :
- 2013
- Publisher :
- Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2013.
-
Abstract
- PURPOSE:To compare the prognostic and predictive features between in situ and invasive components of ductal breast carcinomas. METHODS:We selected 146 consecutive breast samples with ductal carcinoma in situ (DCIS) associated with adjacent invasive breast carcinoma (IBC). We evaluated nuclear grade and immunohistochemical expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), cytokeratin 5/6 (CK5/6), and epidermal growth factor receptor (EGFR) in both components, in situ and invasive, and the Ki-67 percentage of cells in the invasive part. The DCIS and IBC were classified in molecular surrogate types determined by the immunohistochemical profile as luminal (RE/PR-positive/ HER2-negative), triple-positive (RE/RP/HER2-positive), HER2-enriched (ER/PR-negative/HER2-positive), and triple-negative (RE/RP/HER2-negative). Discrimination between luminal A and luminal B was not performed due to statistical purposes. Correlations between the categories in the two groups were made using the Spearman correlation method. RESULTS:There was a significant correlation between nuclear grade (pOBJETIVO: Comparar características prognósticas e preditivas entre os componentes in situ e invasivo de carcinomas ductais da mama. MÉTODOS: Selecionamos 146 amostras mamárias consecutivas com carcinoma ductal in situ (CDIS) associado com carcinoma invasivo (CI) adjacente. Avaliamos grau nuclear e a expressão imunoistoquímica de receptor de estrogênio (RE), receptor de progesterona (RP), receptor do fator de crescimento epidérmico humano 2 (HER2), citoqueratina 5/6 (CK5/6) e o receptor do fator de crescimento epidérmico (EGFR) em ambos componentes, in situ e invasor, e a porcentagem de células marcadas pelo Ki-67 no componente invasivo. CDIS e CI foram classificados nos tipos moleculares, determinados pelo perfil imunoistoquímico, como luminal (RE/RP-positivo/HER2-negativo), triplo-positivo (RE/RP/HER2-positivo), HER2-puro (RE/RP-negativo/HER2-positivo) e triplo-negativo (RE/RP/HER2-negativo). A discriminação entre luminal A e Luminal B não foi feita por motivos estatísticos. Correlações entre as categorias dos dois grupos foram feitas pelo método de correlação de Spearman. RESULTADOS: Houve significante associação entre grau nuclear (p
- Subjects :
- Neoplasias da mama
Carcinoma ductal de mama
Técnicas imunoenzimáticas
Receptores estrogênicos
Receptor, erbB-2
Queratina-5
Queratina-6
Antígeno Ki-67
Marcadores biológicos de tumor
Breast neoplasms
Carcinoma, ductal, breast
Immunoenzyme techniques
Receptors, estrogen
keratin-5
keratin-6
Ki-67 antigen
Tumor makers, biological
Gynecology and obstetrics
RG1-991
Subjects
Details
- Language :
- English, Portuguese
- ISSN :
- 01007203
- Volume :
- 35
- Issue :
- 3
- Database :
- Directory of Open Access Journals
- Journal :
- Revista Brasileira de Ginecologia e Obstetrícia
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.45f3491e521d4ae4aa4e4fd7c80e4990
- Document Type :
- article